6.4.7. Observation. In unselected relapsing patients the median actuarial time to the development of metastasis will be 8 years and the median time from metastasis to death will be a further five years [825]. For patients with EAU Low-Risk BCR features (see Section 6.3.3), unfit patients with a life expectancy of less than ten years or patients unwilling to undergo salvage treatment, active follow-up may represent a viable option. 